Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Metabolism ; 49(10): 1346-51, 2000 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11079827

RESUMEN

Rats fed a sucrose-rich diet ([SRD] 63% wt/wt) up to 270 days develop stable hypertriglyceridemia, impaired glucose tolerance, and insulin insensitivity. The aim of the present study is to investigate whether the hypoglycemic agent troglitazone introduced as a pharmacologic intervention could improve and/or reverse the whole-body insulin insensitivity and related abnormalities present after feeding normal rats with a SRD long-term. For this purpose, male Wistar rats were fed a SRD for 210 days. While half of the animals continued with this diet for up to 270 days, troglitazone (0.2 g/dL wt/wt) was added to the SRD of the other half for up to 270 days. Troglitazone markedly reduced in vivo the hepatic triglyceride secretion rate (TGSR) and enhanced its removal from the circulation, leading to a normalization of plasma triglyceride levels. It also normalized the whole-body peripheral insulin resistance, the glucose homeostasis, and the elevated free fatty acids (FFAs) without detectable changes in plasma insulin levels. The clear alteration of the biphasic pattern of glucose-stimulated insulin secretion in the in vitro perfused beta-cell islets of rats fed the SRD long-term (270 days) was also completely normalized when the SRD was supplemented with troglitazone for 2 months. The normalization of the altered patterns of glucose-stimulated insulin secretion, as well as the enhancement of peripheral insulin sensitivity without detectable changes in plasma insulin, might be largely a result of the significant action of troglitazone in the decrease of circulating lipids and enhancement of whole-body glucose metabolism.


Asunto(s)
Cromanos/farmacología , Glucosa/farmacología , Hipertrigliceridemia/tratamiento farmacológico , Hipoglucemiantes/farmacología , Insulina/metabolismo , Tiazoles/farmacología , Tiazolidinedionas , Animales , Peso Corporal/efectos de los fármacos , Sacarosa en la Dieta/administración & dosificación , Ácidos Grasos no Esterificados/sangre , Secreción de Insulina , Hígado/metabolismo , Masculino , Ratas , Ratas Wistar , Triglicéridos/metabolismo , Troglitazona
2.
Eur J Neurosci ; 10(2): 771-6, 1998 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-9749741

RESUMEN

Chemical lesion of olfactory neuroepitheium induced an up-regulation of the mGlu1a metabotropic glutamate receptor protein in the olfactory bulb, as shown by Western blot analysis. At 2 days after the lesion, the increase in the receptor protein was associated with an increase in mGlu1a mRNA levels; in contrast, at longer times after the lesion (16 days), mRNA levels were reduced in spite of the high expression of the receptor protein, perhaps as a result of product-inhibition of mGlu1 gene expression. Immunohistochemical analysis showed that the increase in mGlu1a induced by olfactory denervation was confined to the glomeruli, which occupy the external portion of the olfactory bulb. Within these structures, mGlu1a receptors are mainly localized on the distal dendrites of mitral cells, which are innervated by the glutamatergic axons of the olfactory nerve. These results demonstrate that the expression of mGlu1a receptors is up-regulated in response to glutamatergic deafferentation, supporting a role for this particular receptor subtype in the physiology of synaptic transmission.


Asunto(s)
Neuronas Aferentes/fisiología , Bulbo Olfatorio/metabolismo , Receptores de Glutamato Metabotrópico/biosíntesis , Regulación hacia Arriba/fisiología , Secuencia de Aminoácidos , Animales , Western Blotting , Desnervación , Epitelio/metabolismo , Inmunohistoquímica , Datos de Secuencia Molecular , Bulbo Olfatorio/citología , Reacción en Cadena de la Polimerasa , ARN Mensajero/biosíntesis , Ratas , Receptores de Glutamato Metabotrópico/genética
3.
Neuroreport ; 8(8): 1949-53, 1997 May 27.
Artículo en Inglés | MEDLINE | ID: mdl-9223083

RESUMEN

Glutamate (Glu) released by olfactory nerve axons acts on postsynaptic ionotropic and metabotropic glutamate receptors expressed by principal neurones and interneurones of the olfactory bulb (OB). Using ZnSO4 lesioning of the rat olfactory mucosa and semiquantitative RT-PCR, we examined the effect of removal of the glutamatergic input to the OB on the expression of mGluR1a, mGluR1b and GluR1 mRNAs. Two days after lesioning, mGluR1a mRNA levels in OB increased by 45%. At this time, the expression of tyrosine hydroxylase (TH) mRNA, which is strictly dependent on olfactory nerve input, was still unchanged. In contrast, 16 days after lesioning, deafferented OB exhibited a decrease in both mGluR1a (-30%) and TH (-40%) mRNAs. GluR1 and mGluR1b mRNA levels were not affected at either time point. These results suggest that alterations in glutamatergic input to OB selectively modulate the expression of the mGluR1 splicing form possessing a longer C-terminal domain.


Asunto(s)
Ácido Glutámico/fisiología , Neuronas Aferentes/fisiología , Bulbo Olfatorio/fisiología , ARN Mensajero/biosíntesis , Receptores de Glutamato Metabotrópico/biosíntesis , Animales , Secuencia de Bases , Desnervación , Inmunohistoquímica , Masculino , Datos de Secuencia Molecular , Plasticidad Neuronal/fisiología , Bulbo Olfatorio/citología , Mucosa Olfatoria/inervación , Vías Olfatorias/citología , Vías Olfatorias/metabolismo , Reacción en Cadena de la Polimerasa , Ratas , Ratas Wistar , Tirosina 3-Monooxigenasa/biosíntesis , Sulfato de Zinc/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA